Advertisement

Topics

Lilly's soft tissue sarcoma treatment gets U.S. approval

10:22 EDT 19 Oct 2016 | Reuters

(Reuters) - The U.S. Food and Drug Administration on Wednesday approved Eli Lilly and Co's treatment for adults with advanced soft tissue sarcoma (STS).

Original Article: Lilly's soft tissue sarcoma treatment gets U.S. approval

NEXT ARTICLE

More From BioPortfolio on "Lilly's soft tissue sarcoma treatment gets U.S. approval"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...